Ascendis Ph.sp.adr 1 Dk 1 buy phonebroker
Start price
17.09.16
/
50%
€18.14
Target price
19.09.16
€22.55
Performance (%)
0.00%
End price
19.09.16
€18.14
Summary
This prediction ended on 19.09.16 with a price of €18.14. phonebroker's BUY prediction for Ascendis Ph.sp.adr 1 Dk 1 closed unchanged from the start price. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ascendis Ph.sp.adr 1 Dk 1 | 4.706% | 4.706% | 31.852% | - |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% | 47.267% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% | 68.687% |
Comments by phonebroker for this prediction
In the thread Ascendis Ph.sp.adr 1 Dk 1 diskutieren
Ascendis Pharma
... ist ein junges biopharmazeutisches Unternehmen, das seine innovative TransCon Technologie zur signifikanten ungedeckten medizinischen Bedarf in seltenen Krankheiten verwendet.